BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.1480
+0.0043 (2.99%)
At close: Sep 4, 2026, 4:00 PM EDT
0.1493
+0.0013 (0.88%)
After-hours: Sep 4, 2026, 7:49 PM EDT
BioRestorative Therapies Market Cap
BioRestorative Therapies has a market cap or net worth of $3.77 million as of September 4, 2026. Its market cap has decreased by -72.68% in one year.
Market Cap
3.77M
Enterprise Value
207.51K
1-Year Change
-72.68%
Ranking
Category
Stock Price
$0.15
ChartMarket Cap Chart
Since November 5, 2021, BioRestorative Therapies's market cap has decreased from $6.50M to $3.77M, a decrease of -41.99%. That is a compound annual growth rate of -10.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 3.80M | -63.46% |
| Dec 31, 2025 | 10.40M | 5.05% |
| Dec 31, 2024 | 9.90M | 20.73% |
| Dec 29, 2023 | 8.20M | -18.81% |
| Dec 30, 2022 | 10.10M | -33.55% |
| Dec 31, 2021 | 15.20M | 133.85% |
| Nov 5, 2021 | 6.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 4.22M |
| Alaunos Therapeutics | 4.14M |
| VivoSim Labs | 4.13M |
| Mustang Bio | 4.11M |
| Addex Therapeutics | 4.10M |
| Onconetix | 4.03M |
| Revelation Biosciences | 4.02M |
| Galmed Pharmaceuticals | 3.89M |